A new vision for lifelong skin wellness.
For decades, co-founders Ami and Monica Mezezi pioneered solutions in IVF, regenerative medicine, and stem-cell science, working with some of the body’s most delicate cells. They learned that cells thrive when given the right environment, precise nourishment, and consistent support.
That question became AVL. Together with a world-class team of scientists and doctors, Ami and Monica are developing breakthrough technologies that redefine how we approach the appearance of skin aging and support lasting skin wellness.
"Healthy-looking skin belongs to all of us, at every age and every stage of life. We founded AVL around a new vision for skincare: not simply reacting to the signs of aging, but helping everyone support lasting skin wellness, resilience, and radiance."
- Ami
Dr. Dendy Engelman is a board certified dermatologist, Mohs surgeon, and leader in medical, cosmetic, and surgical dermatology. She is focused on helping AVL advance the next generation of longevity focused skincare.
Sylwia is a chemist with deep expertise in advanced skincare science, bringing together cutting-edge formulations, scientific validation, and an uncompromising commitment to transparency and sustainability. She helps create products that are as elegant as they are effective, developed with the highest standards for skin, safety, efficacy, and the environment.
Dr. Ivchenko is a skin health expert with a focus on aesthetic medicine, specializing in advanced skin treatment protocols and combined therapies. She supports AVL clinical studies investigating skin processes and the use of AVL for post-treatment wellness.
Vanesa is an expert in medical and cosmetic dermatology, specializing in the use of advanced science-backed formulations for the treatment of skin concerns and overall wellness. She supports AVL’s patient advocacy for in-treatment, post-treatment, and daily use, ensuring the highest levels of personal care.
Dr. Flynn is a stem cell and gene therapy research scientist passionate about advancing next-generation innovation for consumers in cell therapy, organoids, and neuroscience. He is currently investigating AVL SOM3® on the molecular level and it's effect on skin wellness.
